Skip to Content

Promising Efficacy with FLOT-CROSS in Patients with Oligometastatic Esophageal Adenocarcinoma

A recent study evaluates the feasibility and safety of combining FLOT chemotherapy and CROSS chemoradiotherapy (TNT FLOT-CROSS) in the treatment of adenocarcinoma of the esophagus and junction in patients with oligometastases. Charlène J. van der Zijden elaborates on the study on this year’s ASCO GI congress in this MEDtalk.

Charlène J. van der Zijden

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top